114 related articles for article (PubMed ID: 2877729)
1. Enhancement of methotrexate nephrotoxicity after cisplatin therapy.
Goren MP; Wright RK; Horowitz ME; Meyer WH
Cancer; 1986 Dec; 58(12):2617-21. PubMed ID: 2877729
[TBL] [Abstract][Full Text] [Related]
2. Cumulative renal tubular damage associated with cisplatin nephrotoxicity.
Goren MP; Wright RK; Horowitz ME
Cancer Chemother Pharmacol; 1986; 18(1):69-73. PubMed ID: 2875808
[TBL] [Abstract][Full Text] [Related]
3. Increased levels of urinary adenosine deaminase binding protein in children treated with cisplatin or methotrexate.
Goren MP; Wright RK; Horowitz ME
Clin Chim Acta; 1986 Oct; 160(2):157-61. PubMed ID: 2877760
[TBL] [Abstract][Full Text] [Related]
4. Carboplatin (CBDCA), iproplatin (CHIP), and high dose cisplatin in hypertonic saline evaluated for tubular nephrotoxicity.
Goren MP; Forastiere AA; Wright RK; Horowitz ME; Dodge RK; Kamen BA; Viar MJ; Pratt CB
Cancer Chemother Pharmacol; 1987; 19(1):57-60. PubMed ID: 2880677
[TBL] [Abstract][Full Text] [Related]
5. Tubular nephrotoxicity during long-term ifosfamide and mesna therapy.
Goren MP; Pratt CB; Viar MJ
Cancer Chemother Pharmacol; 1989; 25(1):70-2. PubMed ID: 2574077
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study on urinary parameters reflecting renal damage during chemotherapy for urological cancer].
Kitamura Y; Watanabe M; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1993 Feb; 39(2):135-40. PubMed ID: 7682030
[TBL] [Abstract][Full Text] [Related]
7. Cancer chemotherapy-induced tubular nephrotoxicity evaluated by immunochemical determination of urinary adenosine deaminase binding protein.
Goren MP; Wright RK; Horowitz ME; Pratt CB
Am J Clin Pathol; 1986 Dec; 86(6):780-3. PubMed ID: 2878604
[TBL] [Abstract][Full Text] [Related]
8. Urinary N-acetyl-beta-D-glucosaminidase and serum creatinine concentrations predict impaired excretion of methotrexate.
Goren MP; Wright RK; Horowitz ME; Crom WR; Meyer WH
J Clin Oncol; 1987 May; 5(5):804-10. PubMed ID: 3471866
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
Goren MP; Wright RK; Horowitz ME; Pratt CB
Cancer Treat Rep; 1987 Feb; 71(2):127-30. PubMed ID: 2879626
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
11. Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity.
Verplanke AJ; Herber RF; de Wit R; Veenhof CH
Nephron; 1994; 66(3):267-72. PubMed ID: 7910667
[TBL] [Abstract][Full Text] [Related]
12. The protective effect of methylprednisolone against cisplatin-induced nephrotoxicity in patients with urothelial tumors.
Uozumi J; Koikawa Y; Yasumasu T; Tokuda N; Kumazawa J
Int J Urol; 1996 Sep; 3(5):343-7. PubMed ID: 8886909
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase in patients receiving amikacin or cis-platinum.
Diener U; Knoll E; Langer B; Rautenstrauch H; Ratge D; Wisser H
Clin Chim Acta; 1981 May; 112(2):149-57. PubMed ID: 6113066
[TBL] [Abstract][Full Text] [Related]
14. Increased tubular enzyme excretion in preeclampsia.
Goren MP; Sibai BM; el-Nazar A
Am J Obstet Gynecol; 1987 Oct; 157(4 Pt 1):906-8. PubMed ID: 2890304
[TBL] [Abstract][Full Text] [Related]
15. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy.
Goren MP; Wright RK; Pratt CB; Horowitz ME; Dodge RK; Viar MJ; Kovnar EH
Cancer Res; 1987 Mar; 47(5):1457-60. PubMed ID: 3815347
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
Hsu WS; Kao JT; Chen JS
Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
[TBL] [Abstract][Full Text] [Related]
18. [Enzymuria and kidney diseases in childhood].
Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B
Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198
[TBL] [Abstract][Full Text] [Related]
19. Tubular nephrotoxicity after intravenous urography with ionic high-osmolal and nonionic low-osmolal contrast media in patients with chronic renal insufficiency.
Cavaliere G; Arrigo G; D'Amico G; Bernasconi P; Schiavina G; Dellafiore L; Vergnaghi D
Nephron; 1987; 46(2):128-33. PubMed ID: 2885767
[TBL] [Abstract][Full Text] [Related]
20. Two automated procedures for N-acetyl-beta-D-glucosaminidase determination evaluated for detection of drug-induced tubular nephrotoxicity.
Goren MP; Wright RK; Osborne S
Clin Chem; 1986 Nov; 32(11):2052-5. PubMed ID: 3779949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
